Medtronic cardiac devices get label expansion

|About: Medtronic plc (MDT)|By:, SA News Editor

The FDA approves Medtronics' (MDT) CRT devices to treat patients with atrioventricular (AV) block and left ventricular systolic dysfunction.

Patients designated as New York Heart Association Class I, II and III with AV block that need a high percentage of ventricular pacing and have an ejection fraction <=50% will now be able to receive biventricular pacing with the company's CRT devices.

More than 1M Americans suffer from AV block.